JP2025501769A5 - - Google Patents
Info
- Publication number
- JP2025501769A5 JP2025501769A5 JP2024538431A JP2024538431A JP2025501769A5 JP 2025501769 A5 JP2025501769 A5 JP 2025501769A5 JP 2024538431 A JP2024538431 A JP 2024538431A JP 2024538431 A JP2024538431 A JP 2024538431A JP 2025501769 A5 JP2025501769 A5 JP 2025501769A5
- Authority
- JP
- Japan
- Prior art keywords
- akg
- liposome composition
- aqueous medium
- concentration
- liposome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292899P | 2021-12-22 | 2021-12-22 | |
| US63/292,899 | 2021-12-22 | ||
| PCT/US2022/082290 WO2023122759A2 (en) | 2021-12-22 | 2022-12-22 | Oxazolidinone liposome compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501769A JP2025501769A (ja) | 2025-01-23 |
| JP2025501769A5 true JP2025501769A5 (enExample) | 2026-01-05 |
Family
ID=86903807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538431A Pending JP2025501769A (ja) | 2021-12-22 | 2022-12-22 | オキサゾリジノンリポソーム組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20250064739A1 (enExample) |
| EP (1) | EP4452252A4 (enExample) |
| JP (1) | JP2025501769A (enExample) |
| KR (1) | KR20240152302A (enExample) |
| CN (1) | CN118900689A (enExample) |
| AR (1) | AR128071A1 (enExample) |
| AU (1) | AU2022420614A1 (enExample) |
| CA (1) | CA3241952A1 (enExample) |
| IL (1) | IL313709A (enExample) |
| MX (1) | MX2024007588A (enExample) |
| WO (1) | WO2023122759A2 (enExample) |
| ZA (1) | ZA202404799B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102859152B1 (ko) * | 2024-10-24 | 2025-09-12 | 주식회사 한국리포좀 | 합성 지질 리포좀 기반의 일본 뇌염 바이러스 백신 및 그의 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6180134B1 (en) * | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
| EP1656370B1 (en) * | 2003-06-03 | 2012-08-15 | Rib-X Pharmaceuticals, Inc. | Biaryl heterocyclic compounds and methods of making and using the same |
| KR100854211B1 (ko) * | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| US8658203B2 (en) * | 2004-05-03 | 2014-02-25 | Merrimack Pharmaceuticals, Inc. | Liposomes useful for drug delivery to the brain |
| WO2007005754A2 (en) * | 2005-07-01 | 2007-01-11 | Alza Corporation | Liposomal delivery vehicle for hydrophobic drugs |
| US20180344644A1 (en) * | 2015-09-21 | 2018-12-06 | Mallinckrodt Llc | Improved stability of liposome formulations and uses thereof |
| CA3183397A1 (en) * | 2020-06-18 | 2021-12-23 | Daryl C. Drummond | Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof |
-
2022
- 2022-12-22 US US18/723,262 patent/US20250064739A1/en active Pending
- 2022-12-22 JP JP2024538431A patent/JP2025501769A/ja active Pending
- 2022-12-22 CN CN202280089711.3A patent/CN118900689A/zh active Pending
- 2022-12-22 EP EP22912749.3A patent/EP4452252A4/en active Pending
- 2022-12-22 CA CA3241952A patent/CA3241952A1/en active Pending
- 2022-12-22 IL IL313709A patent/IL313709A/en unknown
- 2022-12-22 AU AU2022420614A patent/AU2022420614A1/en active Pending
- 2022-12-22 WO PCT/US2022/082290 patent/WO2023122759A2/en not_active Ceased
- 2022-12-22 KR KR1020247024600A patent/KR20240152302A/ko active Pending
- 2022-12-22 AR ARP220103554A patent/AR128071A1/es unknown
- 2022-12-22 MX MX2024007588A patent/MX2024007588A/es unknown
-
2024
- 2024-06-19 ZA ZA2024/04799A patent/ZA202404799B/en unknown
-
2025
- 2025-12-02 US US19/405,695 patent/US20260083674A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100617921B1 (ko) | 리포솜 조성물 및 퀴놀론의 투여 방법 | |
| CN110621298B (zh) | 阿托品药物组合物 | |
| JP2023531666A5 (enExample) | ||
| JP2022511732A5 (enExample) | ||
| CA2408464A1 (en) | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use | |
| JP2025501769A5 (enExample) | ||
| US20170231910A1 (en) | Pharmaceutical formulations of chelating agents as a metal removal treatment system | |
| IL299155B1 (en) | Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof | |
| KR20150129727A (ko) | 조절 약물 방출 리포솜 조성물 | |
| US20170128366A1 (en) | Pharmaceutical formulations of chelating agents as a metal removal treatment system | |
| US20080124385A1 (en) | Methods for Transmembrane Treatment and Prevention of Otitis Media | |
| WO2023152642A1 (en) | Ophthalmic compositions and methods thereof | |
| US20170239182A1 (en) | Pharmaceutical formulations of and methods to prepare chelating agents for efficient metal removal treatment systems | |
| US20200016169A1 (en) | Ophthalmic solution of bimatoprost | |
| US20170119666A1 (en) | Stable liposomal formulations of alpha 2 adrenergic agonists for ocular delivery | |
| WO2013151518A1 (en) | Capsule formulations comprising ceftibuten | |
| JP7149991B2 (ja) | 発泡剤を含む抗微生物組成物 | |
| AU2024288766A1 (en) | Liposome encapsulated apomorphine | |
| KR20240152302A (ko) | 옥사졸리디논 리포좀 조성물 | |
| CN118161488A (zh) | 一种含有jak抑制剂的眼用制剂及其制备方法和应用 | |
| JPH029816A (ja) | スパガリン類製剤 | |
| MXPA00009675A (en) | Liposome composition and method for administering a quinolone | |
| CN109982696A (zh) | 治疗细菌感染用的脒取代β-内酰胺化合物的脂质体制剂 | |
| HK1035331B (en) | Liposome composition and method for administering a quinolone |